The Sirolimus-Eluting Stent: A Review of Its Use in the Treatment of Coronary Artery Disease

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.3, Iss.3, 2003-01, pp. : 211-230

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Spotlight on the Sirolimus-Eluting Stent in Coronary Artery Disease

By McKeage K. Murdoch D. Goa K.L.

American Journal of Drug Delivery, Vol. 2, Iss. 1, 2004-01 ,pp. : 69-73

Adis International

Access to resources Recommend Favorite

Sirolimus-eluting stent superior for coronary artery restenosis prevention

Inpharma, Vol. 1, Iss. 1389, 2003-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

A polymer-free, sirolimus-eluting stent is as effective as a standard, polymer-based, paclitaxel-eluting stent in the prevention of coronary artery restenosis

Inpharma, Vol. 1, Iss. 1530, 2006-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Sirolimus-eluting stent reduces restenosis, coronary events

Inpharma, Vol. 1, Iss. 1342, 2002-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

The Paclitaxel (TAXUS)-Eluting Stent: A Review of its Use in the Management of de novo Coronary Artery Lesions

By John Waugh Antona J. Wagstaff

American Journal of Cardiovascular Drugs, Vol. 4, Iss. 4, 2004-01 ,pp. : 257-268

Adis International

Access to resources Recommend Favorite